Testing effectiveness (Phase 2)Study completedNCT01218477
What this trial is testing
Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)
Who this might be right for
Leukemia
Bristol-Myers Squibb 33